RE: Cash21 Mar 2026 08:35
Am I the only one thinking this ‘first paying customer’ RNS smells fishy? 🤔
Alludium launches commercially on March 10, does a 7-day trial, and boom – just 9 days later they secure first paying customer. Zero names, zero numbers (how many? what ARR? what deal size?), zero proof.
In a pre-revenue micro-startup with massive AI hype riding on it… what’s stopping them from having their own AI bots or internal AI agents //test accounts/ to subscribe’ to themselves? Self-generated trials converting to ‘paid’ via loop subscriptions – just enough to trigger a nice positive RNS, pump the share price a bit, and keep the story alive for the next warrant exercise or fundraising.